“Gut Microbiota Dysbiosis: Pathogenesis, Diseases, Prevention, and Therapy” (2025), by Yao Shen et al. Genetics and Biochemistry research paper. Original abstract below, unchanged. No free PDF was found.

Gut Microbiota Dysbiosis: Pathogenesis, Diseases, Prevention, and Therapy

Yao Shen, Nairui Fan, Shuxia Ma et al. · April 18, 2025 · Genetics and Biochemistry

Abstract

Dysbiosis refers to the disruption of the gut microbiota balance and is the pathological basis of various diseases. The main pathogenic mechanisms include impaired intestinal mucosal barrier function, inflammation activation, immune dysregulation, and metabolic abnormalities. These mechanisms involve dysfunctions in the gut-brain axis, gut-liver axis, and others to cause broader effects. Although the association between diseases caused by dysbiosis has been extensively studied, many questions remain regarding the specific pathogenic mechanisms and treatment strategies. This review begins by examining the causes of gut microbiota dysbiosis and summarizes the potential mechanisms of representative diseases caused by microbiota imbalance. It integrates clinical evidence to explore preventive and therapeutic strategies targeting gut microbiota dysregulation, emphasizing the importance of understanding gut microbiota dysbiosis. Finally, we summarized the development of artificial intelligence (AI) in the gut microbiota research and suggested that it will play a critical role in future studies on gut dysbiosis. The research combining multiomics technologies and AI will further uncover the complex mechanisms of gut microbiota dysbiosis. It will drive the development of personalized treatment strategies.

Source page DOI: 10.1002/mco2.70168